In: Radiation Oncology, 14 (2019), Nr. 11. pp. 1-8. ISSN 1748-717X
Preview |
PDF, English
- main document
Download (1MB) | Lizenz: ![]() |
Abstract
Background: The implementation of magnetic resonance imaging (MRI) guided radiotherapy (RT) continues to increase. Very limited in-vitro data on the interaction of ionizing radiation and magnetic fields (MF) have been published. In these experiments we focused on the radiation response in a MF of the TK6 human lymphoblastoid cells which are known to be highly radiosensitive due to efficient radiation-induced apoptosis.
Methods: Clonogenicity was determined 12–14 days after irradiation with 1–4 Gy 6 MV photons with or without a 1.0 Tesla MF. Furthermore, alterations in cell cycle distribution and rates of radiation induced apoptosis (FACS analysis of cells with sub-G1 DNA content) were analyzed.
Results: Clonogenic survival showed an exponential dose-dependence, and the radiation sensitivity parameter (α = 1.57/Gy) was in accordance with earlier reports. Upon comparing the clonogenic survival between the two groups, identical results within error bars were obtained. The survival fractions at 2 Gy were 9% (without MF) and 8.5% (with MF), respectively.
Conclusion: A 1.0 Tesla MF does not affect the clonogenicity of TK6 cells irradiated with 1–4 Gy 6MV photons. This supports the use of MRI guided RT, however ongoing research on the interaction of MF and radiotherapy is warranted.
Document type: | Article |
---|---|
Journal or Publication Title: | Radiation Oncology |
Volume: | 14 |
Number: | 11 |
Publisher: | BioMed Central |
Place of Publication: | London |
Date Deposited: | 06 Mar 2019 14:01 |
Date: | 2019 |
ISSN: | 1748-717X |
Page Range: | pp. 1-8 |
Faculties / Institutes: | Service facilities > German Cancer Research Center (DKFZ) Medizinische Fakultät Heidelberg > Radiologische Universitätsklinik Medizinische Fakultät Heidelberg > Heidelberg Ion-Beam Therapy Center (HIT) |
DDC-classification: | 610 Medical sciences Medicine |
Uncontrolled Keywords: | MRI guided radiotherapy, MR Linac, In-vitro experiment, Normal human cells, TK6 human lymphoblastoid cells |